Topic:

April 2024

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

The Lupus Canada Annual General Meeting 2026

Read

Lupus Canada Impact Report 2025 | Advocacy, Awareness & Research Outcomes

Read

Biogen Lupus Research | New Treatments in Development

Read